Blood-filtering device for severe infection with immune weakness
Part of Infections clinical trials.
This trial tests a new blood-filtering device called HemoSystem REBOOT in people with sepsis who have a weakened immune system. The goal is to see if it's safe and can boost the body's ability to fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with sepsis (a severe infection affecting your whole body) and currently in the intensive care unit (ICU) or step-down unit
- Have low blood pressure that needs medication to keep it above a certain level
- Show signs of a weakened immune system caused by the infection, confirmed by two blood tests taken about a day apart
- Not currently taking certain immune-suppressing medicines or high-dose steroids (except for short-term sepsis treatment)
- Weigh at least 50 kg (about 110 pounds) and have a normal platelet count
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This study tests a blood-filtering treatment for people with septic shock, a severe infection that causes very low blood pressure. The treatment aims to remove harmful substances from the blood to help patients recover.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.